Kyverna Therapeutics, Inc. — All Filings
151 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-3
S-8
SC 13D
SC 13G
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0000950170-25-070286 | May 13, 2025 | — |
| EFFECT | — | 9999999995-25-001121 | Apr 15, 2025 | — |
| 4 | 4 | 0000950170-25-054345 | Apr 15, 2025 | Apr 11, 2025 |
| 4 | 4 | 0000950170-25-054344 | Apr 15, 2025 | Apr 11, 2025 |
| 4 | 4 | 0000950170-25-054342 | Apr 15, 2025 | Apr 11, 2025 |
| 424B5 | 424B5 | 0000950170-25-054293 | Apr 15, 2025 | — |
| ARS | ARS | 0000950170-25-053707 | Apr 14, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0000950170-25-053703 | Apr 14, 2025 | — |
| DEF 14A | DEF 14A | 0000950170-25-053699 | Apr 14, 2025 | May 29, 2025 |
| CORRESP | — | 0000950170-25-053136 | Apr 11, 2025 | — |
| UPLOAD | — | 0000000000-25-003502 | Apr 1, 2025 | — |
| 8-K | 8-K | 0000950170-25-046176 | Mar 27, 2025 | — |
| S-8 | S-8 | 0000950170-25-046168 | Mar 27, 2025 | — |
| S-3 | S-3 | 0000950170-25-046162 | Mar 27, 2025 | — |
| 10-K | 10-K | 0000950170-25-046074 | Mar 27, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0000950170-25-046052 | Mar 27, 2025 | — |
| 4 | 4 | 0000950170-25-023428 | Feb 19, 2025 | Feb 14, 2025 |
| 4 | 4 | 0000950170-25-008961 | Jan 24, 2025 | Jan 22, 2025 |
| 3 | 3 | 0000950170-25-008960 | Jan 24, 2025 | Jan 22, 2025 |
| 8-K | 8-K | 0000950170-25-007220 | Jan 21, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-002831 | Jan 13, 2025 | — |
| S-8 | S-8 | 0000950170-24-131097 | Nov 26, 2024 | — |
| 8-K | 8-K | 0000950170-24-131074 | Nov 26, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-126366 | Nov 13, 2024 | Sep 30, 2024 |
| 8-K | 8-K | 0000950170-24-126342 | Nov 13, 2024 | Nov 8, 2024 |
| SC 13G | SC 13G | 0001104659-24-116359 | Nov 12, 2024 | — |
| 4 | 4 | 0000950170-24-116840 | Oct 24, 2024 | Oct 21, 2024 |
| 3 | 3 | 0000950170-24-116839 | Oct 24, 2024 | Oct 21, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-089095 | Oct 21, 2024 | Oct 20, 2024 |
| 4 | 4 | 0000950170-24-107968 | Sep 18, 2024 | Sep 16, 2024 |
| 4 | 4 | 0000950170-24-107967 | Sep 18, 2024 | Sep 16, 2024 |
| 3 | 3 | 0000950170-24-107965 | Sep 18, 2024 | Sep 16, 2024 |
| 3 | 3 | 0000950170-24-107962 | Sep 18, 2024 | Sep 16, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-078736 | Sep 16, 2024 | Sep 13, 2024 |
| 10-Q | 10-Q | 0000950170-24-095462 | Aug 12, 2024 | Jun 30, 2024 |
| 8-K | 8-K | 0000950170-24-095433 | Aug 12, 2024 | — |
| 8-K | 8-K | 0000950170-24-083570 | Jul 15, 2024 | — |
| UPLOAD | — | 0000000000-24-007869 | Jul 11, 2024 | — |
| 8-K | 8-K | 0000950170-24-073312 | Jun 14, 2024 | — |
| 4 | 4 | 0000950170-24-071493 | Jun 10, 2024 | Jun 6, 2024 |
| 4 | 4 | 0000950170-24-065983 | May 29, 2024 | May 28, 2024 |
| 10-Q | 10-Q | 0000950170-24-059628 | May 14, 2024 | Mar 31, 2024 |
| 8-K | 8-K | 0000950170-24-059613 | May 14, 2024 | — |
| SC 13D | SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP | 0001999371-24-005643 | May 3, 2024 | — |
| 10-K | 10-K | 0000950170-24-036481 | Mar 26, 2024 | Dec 31, 2023 |
| 8-K | 8-K | 0000950170-24-036410 | Mar 26, 2024 | — |
| SC 13G | SC 13G | 0001104659-24-026552 | Feb 22, 2024 | — |
| 4 | 4 | 0000950170-24-015479 | Feb 14, 2024 | Feb 12, 2024 |
| 4 | 4 | 0000950170-24-015473 | Feb 14, 2024 | Feb 12, 2024 |
| 4 | 4 | 0000950170-24-015465 | Feb 14, 2024 | Feb 12, 2024 |